Antigen-or mitogen-stimulated T lymphocytes produce factors that can induce a number of functional and biochemical modifications in macrophage populations. These modifications include increases in endocytic, biosynthetic, secretory, and effector cell functions, as well as changes in membrane physiology and composition (1) (2) (3) (4) . This process has been called macrophage activation and the iymphokines that induce these effects are known as macrophage-activating factors (MAF).'
labeled IFN was applied to the top of the BioGel P-6 and the tubes were centrifuged as above. Protein-bound, but not free, '25I was eluted from the gel by this procedure and collected at the bottom of the 12 X 75 mm tubes. The P-6 tube was washed once with 100 tA of buffer and the two eluted volumes were combined. Recovery of IFN was essentially 100% as assessed with the quantitative MAF assay. Typical preparations were labeled to a specific activity of 7.6 ~Ci/ug. ~25I-IFN-~ was stored at 4°C and retained biological activity for at least 2 wk.
Alpha and Beta Interferons. These murine IFN were purchased from Lee Biomolecular Laboratories (San Diego, CA). IFN-a had a specific activity of 5 x 105 IRU/mg, and IFN-3of 1.5 × l07 IRU/mg. Peritoneal Macrophages. Peritoneal exudate cells (PEC) were harvested as described previously by lavage from mice that had been injected intraperitoneally 3 d previously with 1.5 ml of 10% protease peptone (Difco Laboratories, Detroit, MI) (5) . Rats, hamsters, and guinea pigs were injected with 5% casein 5 d before the PEC were harvested. Macrophage monolayers were prepared by seeding the PEC suspension into flat-bottom 96-well tissue culture plates (Costar, No. 3696, Cambridge, MA) or 6-well tissue culture plates (Costar, No. 3506 ). The cells were adhered for 2 h at 37°C and the plates washed vigorously to remove nonadherent cells.
Mouse Bone Marrow-derived Macrophages. Macrophages derived from bone marrow cultures were obtained according to the method of Meerpohl et al. (20) with some modifications. Mice were killed by cervical dislocation and both femurs were dissected free of adherent tissue. The ends of the bones were cut off and the marrow tissue eluted by irrigation with PBS. Cells were suspended by vigorous pipetting and washed by centrifugation, l0 T cells were cultured in a nontissue culture plastic 150-mm petri dish (Lab-Tek 4030, Miles Laboratories, Inc., Naperville, IL) in 50 ml of DME containing 2 mM L-glutamine, 1 mM Na pyruvate, 50 U/ml penicillin, 50 #g/ml streptomycin, 20% heat-inactivated horse serum, and 30% L cell-conditioned medium. The cell suspensions were incubated at 37°C in a humidified 5% CO~ atmosphere. After 6-9 d, macrophages that were loosely adherent to the dishes were harvested with cold PBS and used. Human Cells. Human peripheral blood monocytes, lymphocytes, and polymorphonuclear leukocytes (PMN) were purified from heparinized, normal venous blood by discontinuous density gradient centrifugation on FicolI-Urografin (21) . The upper layer contained a mixture of monocytes and lymphocytes, while 98% of PMN were present in the lower layer. Erythrocytes were obtained at the bottom of the tube. Monocytes were separated from lymphocytes by adherence onto autologous serum-treated plastic plates according to the method of Fischer et al. (22) . The purity of all cell preparations was >98% as assessed by cytocentrifugation and Giemsa-peroxidase staining (23) . Preparation of Membranes from Bone Marrow-derived Macrophages. Membranes were prepared according to the procedure of Gabel et al. (24) . In brief, cells were disrupted with a sonicator and the cell lysates centrifuged at 850 g for 10 min. The resulting low speed supernatant was then recentrifuged at 40,000 g for 30 rain. Membrane pellets were resuspended by homogenization and washed three times. Membrane preparations were stored at -70°C. Cultured Cell Lines. The human histiocytic lymphoma cell line (U0sT) and the murine mastocytoma cell line (P815) were maintained in RPMI supplemented with 2 mM eglutamine, 50 U/ml penicillin, 50 #g/ml streptomycin, 1 mM Na pyruvate, 0.075% (wt/ vol) Na bicarbonate, and 10% heat-inactivated FCS. Murine T cell hybridomas TH4.4, 24/G1, and 1.19 and the murine fibrosarcomas L929, TU5, and 1023 were maintained in DME supplemented with 2 mM L-glutamine 50 U/ml penicillin, 50 ug/ml streptomycin, 1 mM Na pyruvate, and 10% FCS. Two murine macrophage cell lines were also used: P388D~ was maintained in RPMI and J774 in MEM supplemented with 2 mM L-glutamine, 1 mM pyruvate, 10 mM nonessential amino acids, 0.075% (wt/vol) Na bicarbonate, 50 ug/ml ofgentamicin, and 10% FCS. Measurement of MAF Activity. MAF was quantitated by measurement of its ability to induce nonspecific tumorilytic activity in peptone-elicited C3HeB/FeJ macrophages toward P815 mastocytoma cells, as detailed elsewhere (5) Binding Studies with ~25I-recombinant IFN-7. Five million bone marrow-derived mac-rophages125 or the. macrophage cell line P388D1 were incubated with different concentrauons of I-IFN-7 m a total volume of 150 #1 with RPMI-supplemented medium. After 2 h at 4 ° C, 120 tsl was applied to 250 tA of an oil mixture consisting of six parts dioctylpthalate and four parts dibutylpthalate (Aldrich Chemical Company, Inc., Milwaukee, WI) in 400 #1 polyethylene microfuge tubes (VWR Scientific, Inc.) and microfuged at 4°C for 1 min at 9,000 rpm in a Beckman microfuge 12. Tubes were sectioned and the radioactivity of the pellet and supernatant counted. Specific binding was defined as the difference between total binding and the nonspecific binding occurring in the presence of a 500-fold excess of unlabeled IFN-7. Similar studies were carried out using membranes from bone marrowderived macrophages except that membranes were incubated with IFN-7 in the following buffer: 25 mM Hepes, pH 7/0.1 M NaCl/5 mM sodium phosphate/0.34 units per ml soybean trypsin inhibitor/0.5% saponin. Free and membrane-associated IFN were separated by centrifugation through 20% sucrose.
Monoclonal Antibodies. Monoclonal antibodies to recombinant IFN-7 were produced by fusion of immune Armenian hamster splenocytes with HAT-sensitive murine myeloma cell lines, as will be described elsewhere. The resulting hybridomas were cloned three times by limiting dilution. Monoclonal antibodies were purified from tissue culture supernatants on a column of staphylococcal protein A Sepharose (Pharmacia Fine Chemicals, Piscataway, N J).
Results
Demonstration of MAF Absorption. For these studies, MAF has been defined as the lymphokine that primes macrophages for expression of nonspecific tumorilytic activity toward P815 mastocytoma cells. As a source of MAF, we used the supernatant from a Con A-stimulated culture of the murine T cell hybridoma 24/G1. This supernatant contained 55,000 U of MAF activity/ml and 833 IRU IFN-~,/ml. We have previously shown that all the MAF activity in this supernatant was attributable to IFN-% By titration against purified recombinant murine IFN-% the supernatant was estimated to contain 190 ng IFN-~/ml. Fig. 1 demonstrates that MAF activity was removed from the 24/G1 supernatant following exposure to elicited peritoneal exudate macrophages (EPM). In this experiment 1 ml of supernatant was diluted 1/100 (550 U/ml) and was incubated for 4 h at 37°C either in empty wells or in wells containing 6 x 106 adherent EPM. The supernatant from the control well displayed 460 U MAF/ ml as compared with 530 U/ml of unincubated supernatant, indicating that MAF activity was stable to the 37 °C incubation. However, after exposure to EPM, the supernatant contained only 92 U/ml of MAF activity. This represents an 80% loss of MAF activity. l. Demonstration of MAF absorption by macrophages, 6 x 106 EPM were incubated for 4 h at 37°C with 1 ml of 24/G1 supernatant diluted 1/100. As control, the diluted supernatant was incubated without macrophages. Following incubation, the supernatants were removed and the remaining MAF activity measured using freshly explanted macrophages.
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Macr0phages xlO" 106 EPM or 3 x 106 bone marrow-derived macrophages and 12 × 106 of either cell population removed 100% of the 24/G1 derived MAF. The reduction of MAF activity was also dependent on the initial input of the lymphokine. At MAF dilutions of 1/25, 1/50, 1/100, 1/150, and 1/200, the amount of activity removed following treatment with 6 × 10 6 EPM for 4 h at 37°C was 40%, 57%, 73%, 92%, and 100%, respectively. Absorption was time dependent at 37°C but not at 4°C or 22°C ( Fig. 3 ). At all three temperatures, exposure of 24/G1 supernatants to 6 × 10 6 EPM for 30 min, led to removal of ~40% of the MAF activity. Assuming that the supernatants contained 190 ng IFN-3,/ml, an estimate can be made that EPM bound or consumed ~2,000 molecules of IFN-T/cell. While longer incubation at 4°C or 22°C did not result in additional removal of MAF activity, incubation at 37°C effected a time-dependent increase in MAF absorption. After 4 h at 37 °C, 85% of the MAF activity was lost from 24/G1 supernatants and all the activity was removed when the absorption was carried out for 24 h. Bone marrow-derived macrophages were equivalent to EPM in these experiments. Similar results were also obtained using other 24/G1 supernatants or supernatants of Con A-stimulated normal splenic cells.
Controls to Indicate that Removal of MAF Activity was a Result of Absorption. The ability of macrophages to rapidly (30 rain) remove MAF activity from 24/G1 supernatants at 4°C suggested that the loss of activity was the result of IFN-3, absorption. To further substantiate this hypothesis three additional experiments were performed.
To rule out the possibilities that (a) the MAF/IFN-? was degraded or altered by macrophage-derived factors or (b) treated macrophages produced substances such as prostaglandins that could interfere with the subsequent quantitation of MAF activity, a mixing experiment was performed as outlined in Table I . Supernatants containing untreated MAF or MAF preincubated either in empty wells or with EPM were mixed in various combinations with medium from EPMcontaining wells. In all cases, the amount of MAF activity that was measured in the mixtures closely approximated the theoretical values calculated from the mixture composition. No difference in these results were seen when 10 -s M indomethacin was present during preparation of the various supernatants. Macrophages incubated with MAF for 2 and 4 h absorbed 46% and 75% of the activity, respectively, in the absence of indomethacin and 42% and 74% of the activity was removed in the presence of the cyciooxygenase inhibitor.
In a second series of experiments, paraformaldehyde-fixed or heat-killed (56°C, 30 rain) EPM were compared to normal EPM for the ability to absorb MAF activity (Table I1 ). After 2 h of incubation the untreated cells had removed 61% of the MAF activity, while the fixed cells had removed only 38%. At subsequent time points the native cells continued to absorb MAF activity, while the fixed cells did not. Cells heated to 56°C for 30 min were nonviable as evidenced by release of the cytoplasmic marker lactate dehydrogenase and their permeability to trypan blue. These cells did not express tumoricidal activity when treated with 24/GI supernatants and also absorbed <10% of the MAF activity even when the incubation period was prolonged to 24 h. A third set of experiments was performed to assess the specificity of the absorption. Macrophages were incubated with a supernatant containing 25 U/ ml IL-2 and 550 U/ml MAF for 2, 4, and 24 h at 37°C. After incubation, the remaining MAF and IL-2 activities were quantitated ( Fig. 4) . When compared to the corresponding control, IL-2 showed 17%, 4%, and 13% absorption after 2, 4, and 24 h, respectively, while for the same periods of incubation, 45%, 83%, and 100% of MAF was absorbed. Similar results were obtained using 50 or 12.5 U/ml of IL-2. The variation between the values obtained for the IL-2 after incubation with macrophages was similar to the variation obtained with the control values, suggesting that IL-2 was not absorbed by macrophages.
Time of Incubation
Relationship between Time of Absorption and Development of Cytotoxicity.
To study the relationship between absorption and development of the tumoricidal response, macrophages were incubated at 37 °C with the 24/G1 supernatant for periods of time between 1 and 6 h. After each incubation period, the supernatant was removed and analyzed for MAF activity while the macrophages were washed and then challenged with P815 in the presence of a second signal (HKLM). Fig.  5 shows that although MAF is absorbed progressively over the period of incubation, a minimum exposure of 4 h is required before the macrophage can express tumorilytic activity. During this critical period of incubation, 82% of the MAF has been absorbed. No change was observed in the minimum incubation time needed to elicit a tumoricidal response when higher concentrations of MAF were used.
Cell and Species Specificity of Absorption. Elicited and resident peritoneal exudate murine macrophages are known to differ in their responsiveness to IFN-% In our experimental assay system, only the freshly explanted elicited cell population developed IFN-dependent nonspecific tumorilytic activity (Table III) . This responsiveness was rapidly lost in culture and was also not expressed by freshly explanted or cultured resident peritoneal exudate cells. Table III shows that the defect is not related to IFN-'y binding by the cells, since both the responsive and However, values of only 320 U and 4,300 U were obtained when the assay was performed with P388Dl or J774, respectively. When examined after 6 h incubation with the hybridoma supernatant, the two cell lines also showed a defective Table V compares cells from a number of different species for their ability to absorb 24/Gl-derived MAF activity. Absorption appears to display a degree of species specificity. When peritoneal exudate macrophages from four rodent species were compared, only murine cells absorbed MAF activity during the first 4 h of incubation. After 24 h of incubation, rat macrophages were also found to absorb or consume a small amount (37%) of MAF activity. Human polymorphonuclear leukocytes, lymphocytes, and erythrocytes did not absorb murine MAF. However, human monocytes absorbed 33% of the activity following in vitro culture for 24 h. This result agrees with the observation that after 1-3 d in culture, human peripheral blood monocytes acquire the ability to respond to murine IFN-3, and can express nonspecific tumoricidal activity toward the human melanoma cell line A357 (Buchmeier, N. A., and R. D. Schreiber, unpublished observation). In contrast to normal human peripheral blood cells, the human histiocytic lymphoma cell line Ugs7 was quantitatively equivalent to murine macrophages in effecting absorption of 24/Gl-derived MAF activity.
Absorption of Recombinant IFN-y by Macrophages.
We have previously found that the MAF activity displayed by purified recombinant murine IFN-3, was equivalent, on an antiviral activity basis, to the MAF activity expressed by the T cell hybridoma-derived IFN-3, (27) . This observation prompted a comparison of the ability of macrophages to absorb natural arid recombinant IFN-3,. For these experiments, the recombinant 1FN-3, was diluted such that the final solution contained the same amount of MAF activity as a 1/100 dilution of the 24/G1 supernatant (550 U/ml). After 2 and 4 h incubation with normal EPM the amount of absorption of the recombinant IFN-3, (32% and 76%, respectively) was similar to that of the natural IFN (44% and 86%, respectively, Table VI ). Moreover, P388D~ that was deficient in absorbing the natural IFN-3, was also deficient in absorbing the recombinant material.
In order to directly visualize the interaction of IFN-3, with the macrophage surface, recombinant IFN-3, was bound to fluorescent microspheres and incubated at 4°C with macrophage populations. EPM exposed to microspheres bearing IFN-7 bound one to nine beads per cell (Fig. 6a) . Staining of the cell population was heterogeneous with 35% of the cells binding less than three beads. When microspheres were used that did not carry IFN-% but that had been blocked by incubation with ethanolamine, no binding occurred (Fig. 6b) . Preincubation of EPM with high concentrations of 24/G 1 supernatant, abrogated binding of IFN-7-covaspheres, indicating that binding was IFN mediated (Fig.  6c ). Fig. 6d shows that P388D~ did not bind IFN-7-coated microspheres. This result thus agrees with the absorption data.
Demonstration of a Specific IFN-7 Receptor on Macrophages: Quantitation of the Interaction between Recombinant IFN-7 and Macrophages. The data presented
thus far indicate that natural and recombinant IFN-3, bound to macrophages in a similar fashion. Because of its availability, the purified recombinant material was used to quantitate the interaction of IFN-~, with the macrophage surface. Recombinant IFN-7 was first subjected to HPLC gel filtration to remove any degraded material that may have formed during storage. As detected by ultraviolet absorption at 280 nM, two molecular weight species eluted from the column with symmetrical elution profiles (data not shown). The first peak displayed an apparent molecular weight of 32,000, while the second peak corresponded to an Mr of 5,000-7,000. Only the material in the 32,000-dalton peak expressed MAF and antiviral activities and reacted with monoclonal antibodies to IFN-% Fig. 7 shows the results of a binding experiment that used bone marrowderived macrophages and 125I-labeled HPLC-purified recombinant IFN-7. Specific binding has been defined as the binding that is inhibited in the presence of a 500-fold excess of unlabeled IFN-7. In these experiments -80% of the total binding was specific. By Scatchard plot analysis, the cells were found to carry, per cell, 15,200 receptors that bound ligand in a homogeneous, noncooperative manner and displayed an affinity (Ka) of 1.18 X 10 s M ~1. The average of three such experiments produced mean values of 12,000 receptors per cell and a Ka of 0.9 x l0 s M -1. Analysis of IFN-3, binding to P388Da indicated that the cell line carried only 760 receptors per cell, which is 6.3% that displayed by bone marrow-derived macrophages. Similar experiments were performed on mem- was then added to each tube and incubation continued for 2 h at 4°C. Specific binding and separation of bound and free ~251-1FN-3, as in Fig. 7 . For these studies the T cell hybridoma supernatant or a sham supernatant were concentrated 10-fold before use by ultrafihration.
brane preparations of bone marrow-derived macrophages. These studies showed that 17 #g of membranes (weight recovered from 107 cells) specifically bound a maximum of 5 ng of IFN-3'. Fig. 8 demonstrates the specificity of the binding reaction. Preincubation of the bone marrow macrophages with different amounts of 24/Gl-derived IFN-y inhibited the uptake of 125I-recombinant IFN-3' in a dose-dependent fashion. Addition of 208 IRU of natural IFN-y to the reaction mixture caused a 62% reduction in binding of a comparable amount of the recombinant material (290 IRU), indicating that the two products bound to the cells with comparable affinity. Crude preparations of IFN-/3 displayed a weak ability to inhibit binding of recombinant IFN-3, when added in large excess (8,000 IRU), while IFN-a displayed no inhibitory activity at all.
Relationship between Receptor Binding and Macrophage Activation. Two monocional antibodies to IFN-~, (H2 and H21) that differentially modulate IFN-3,dependent biological responses in macrophages were used to demonstrate the involvement of the IFN-'y receptor in macrophage activation. H21 has been found to inhibit the ability of IFN-3' to induce nonspecific tumorilytic activity or Ia expression in macrophages, while H2 was found to enhance these activities. 2 Fig. 9 shows that inhibition or enhancement of IFN-induced macrophage functions correlates with the interaction of IFN-~ with the IFN-'), receptor. Depending on the input of IFN-"y, an excess of H21 inhibited 100% of the cellular uptake of IFN-3,, while H2 enhanced binding as much as 3.3-fold. No alteration of binding was observed when normal hamster IgG was substituted for the monoclonals.
Discussion
This report documents the existence of a IFN-~r-receptor on murine macrophages and indicates that receptor engagement is a necessary first step in the induction of nonspecific tumorilytic activity in these cells. Macrophages bound either purified recombinant IFN-~ produced in bacteria or natural IFN-'y derived from either a murine T cell hybridoma or normal murine splenic cells. Binding was specific, saturable, of high affinity, and resulted in the induction of a biological response in appropriate macrophage populations. These parameters thus indicate that IFN-~ was binding to a specific cell surface receptor.
Although substantial quantities of purified natural murine IFN-'y were not available for these studies, the interaction could be demonstrated by quantitating the macrophage-dependent absorption of I FN-~ from supernatants of stimulated T lymphocytes. We chose to quantitate MAF activity as an indicator of IFN-'y, 
RECEPTOR FOR INTERFERON-q, ON MACROPHAGES
since the macrophage was the target cell for this activity and since the MAF assay was more quantitative and 10 times more sensitive than the antiviral activity assay. For most of the studies, a supernatant of the 24/G1 T cell hybridoma was used. Previous studies have shown that the MAF activity produced by 24/G1 was largely due to IFN-3, (6, 8, 27) . Recently, using monoclonal antibodies to recombinant IFN-'y we have found that IFN-"r represented the only MAF in these supernatants and in Con A-stimulated supernatants of normal murine splenic cells, z The absorption experiments showed that the ability of macrophages to remove MAF activity from culture supernatants was dependent on cell number, temperature, time of incubation, and displayed species specificity. The data also indicated that the activity was removed by cellular absorption and not by extracellular degradation or production of macrophage-derived factors that interfered with MAF quantitation. This conclusion was supported by the observations that (a) absorption occurred at 4 o C, (b) paraformaldehyde-fixed murine macrophages absorbed MAF activity, (c) absorption of 24/G1 MAF was effected by murine macrophages but not hamster-or guinea pig-derived cells, (d) absorption was specific since treated supernatants showed a selective reduction in MAF activity but not I L-2 activity, and (e) mixing 24/G 1 supernatants with macrophage culture supernatants did not affect the levels of MAF activity.
While these results strongly suggested the existence of an IFN-3, receptor on murine macrophages, they had to be validated with quantitative uptake experiments using radiolabeled IFN-y. This was accomplished with ~2~I-labeled purified recombinant IFN-3'. Scatchard plot analysis of the binding data showed that the binding of IFN-7 to macrophages at 4°C was noncooperative (linear Scatchard plots), saturable (~12,000 receptors/cell), specific (binding was inhibitable by unlabeled IFN-3'), and of moderately high affinity (K a = 0.9 X 10 8 M-I), Binding could be demonstrated to membrane preparations as well as to intact cells.
Several lines of evidence indicated that the interaction of the receptor with natural IFN-3, was comparable to that observed with the recombinant material. Both types of IFN-y expressed equal MAF activities when compared on an antiviral activity basis (8, 27) . Hybridoma-derived and recombinant IFN-3' were absorbed in an identical fashion by normal macrophages and were not absorbed by the P388D1 cell line. Subsequent quantitation of ~25I-recombinant IFN-3, binding to this cell line indicated that P388D1 carried only 6.3% as many receptors as were expressed on normal macrophages. The number of receptors on normal macrophages determined by the absorption experiments with natural IFN-3, (2,000-5,000 receptors/cell) was comparable to the number obtained by measurement of l~5I-recombinant IFN-y binding (12,000 receptors/cell). Finally, unlabeled, natural IFN-3, could quantitatively compete with the labeled recombinant material for receptor binding. This result indicated that the two IFN-3' preparations bound to the receptor with similar affinities.
The monoclonal antibody studies indicate that binding of IFN-y to its cell surface receptor is a necessary step for the induction of a biological response in macrophages. Modulation of the binding reaction correlated with appropriate increases or decreases in the eventual induction of tumoricidal activity. It is most likely that the inhibition produced by H21 reflected its ability to directly or sterically block regions of IFN-~, that interact with the receptor. The enhancement observed with H2 probably reflects the formation of soluble immune complexes that were multimeric with respect to IFN-~, and that formed multipoint attachments to the macrophages through IFN-~, receptors. These possibilities are currently under examination.
The results presented in this communication are consistent with observations made in other laboratories. The ability of macrophages to remove MAF activity from lymphokine preparations was previously reported by Yamamoto and Tokunaga (28) . However, this earlier study used a MAF of unknown biochemical identity and failed to establish absorption as the mechanism for MAF removal. A number of other studies have indicated that MAF-dependent induction of tumoricidal activity is not H2 restricted (29) . Our experiments support this conclusion, since macrophages from mice with different H2 backgrounds absorbed MAF activity to comparable degrees.
The species specificity of the binding agrees with other results obtained independently. Although murine IFN-y did not bind to hamster or guinea pig macrophages, it did bind to cultured normal human monocytes and to the human histiocytic lymphoma cell line U937. Both natural and recombinant murine IFNy have been found to activate normal human peripheral blood monocyte-derived macrophages for nonspecific tumoricidal activity (Buchmeier, N. A., and R. D. Schreiber, unpublished data). Moreover, unlabeled recombinant murine IFN-3, can inhibit binding of ~25I-human recombinant IFN~" to human mononuclear phagocytes (Celada, A., and R. D. Schreiber, manuscript in preparation). These results thus clearly differentiate IFN-~,-dependent MAF activity from IFN-yantiviral activity on fibroblasts. The latter displays strict species specificity.
To date only one other series of studies exists that suggests the existence of a cellular IFN-y receptor. Anderson et al (30, 31) have demonstrated binding of purified natural human IFN-y to human GM-258 fibroblasts. These fibroblasts expressed 8,000-20,000 receptors/cell and bound ligand with a Kd of 2-6 × 10 -9 M (or a K~ of 1.7-5 X l0 s M-l). These parameters are similar to the values obtained in our study. We have also documented the presence of an IFN-'y receptor on the murine fibroblast cell line L9~9 as well as several other cell types using the MAF absorption technique. However, it is not yet known whether the receptors on the different cell types are identical or distinct. More structural and immunochemical data about the IFN-'r receptor is needed before this question can be answered. Work is currently underway to isolate and characterize the macrophage ]FN-'y receptor.
The identification of a IFN-y receptor on macrophages that participates in the induction of nonspecific tumoricidal activity is the first step at understanding macrophage activation at the molecular level. Work is currently in progress to determine the fate of the receptor-bound ligand and whether receptor engagement is sufficient to initiate a tumoricidal response. The quantitation of this receptor-ligand interaction should also provide a means of defining the mechanisms of action of other factors that have been reported to have MAF activity but not antiviral activity (32) (33) (34) .
Summary
Gamma-interferon (IFN-~) is the macrophage-activating factor (MAF) produced by normal murine splenic cells and the murine T cell hybridoma 24/G 1 that induces nonspecific tumoricidal activity in macrophages. Incubation of 24/ G1 supernatants diluted to 8.3 IRU IFN--y/ml with 6 x 106 elicited peritoneal macrophages or bone marrow-derived macrophages for 4 h at 37°C, resulted in removal of 80% of the MAF activity from the lymphokine preparation. Loss of activity appeared to result from absorption and not consumption because (a) 40% of the activity was removed after exposure to macrophage for 30 min at 4 ° C, (b) no reduction of MAF activity was detected when the 24/G 1 supernatant was incubated with macrophage culture supernatants, and (c) macrophage-treated supernatants showed a selective loss of MAF activity but not interleukin 2 (IL,2) activity. Absorption was dependent on the input of either IFN-~, or macrophages and was time dependent at 37 °C but not at 4 o C. With four rodent species tested, absorption of murine IFN-3, displayed species specificity. However, cultured human peripheral blood monocytes and the human histiocytic lymphoma cell line U937 were able to absorb the murine lymphokine. Although the majority of murine cell lines tested absorbed 24/G1 MAF activity, two murine macrophage cell lines, P388D~ and J774, were identified which absorbed significantly reduced amounts of natural IFN-7. Purified murine recombinant IFN-3, was absorbed by elicited macrophages but not by P388D~. Normal macrophages but not P388D~ bound fluoresceinated microspheres coated with recombinant IFN-y and binding was inhibited by pretreatment of the normal cells with 24/G1 supernatants. Scatchard plot analysis showed that 12,000 molecules of soluble 125I-recombinant IFN-7 bound per bone marrow macrophage with a Ka of 0.9 x 10 s M -l. Binding was quantitatively inhibitable by natural IFN-3 ~ but not by murine IFN~. IFN-/3 competed only weakly. Monoclonal antibodies against IFN-2¢ either inhibited or enhanced MAF activity by blocking or increasing IFN-7 binding to macrophages, respectively. These results indicate that IFN-7 reacts with a receptor on macrophage in a specific and saturable manner and this interaction initiates macrophage activation.
